| NCT Number | NCT06762717 |
| Lead Sponsor | Boston Scientific Corporation |
| Conditions | Paroxysmal AF |
| Enrollment | 500 participants |
| Start Date | 2025-10-23 |
| Primary Completion | 2027-12-31 (estimated) |
| Study Completion | 2029-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-29 |